TNKASE (tenecteplase) - Roche, Boehringer Ingelheim
Risk factors for hemorrhagic transformation after tenecteplase therapy in acute ischemic stroke: A retrospective observational study. (PubMed, Medicine (Baltimore)) - Sep 27, 2026 - "The model showed acceptable apparent calibration and discrimination (area under the receiver operating characteristic curve = 0.86); however, 14 candidate variables were evaluated for only 28 events (approximately 2 events per variable), creating a substantial risk of overfitting. These findings are hypothesis-generating and require validation in larger independent cohorts." 
Journal • Observational data • Retrospective data • Cardiovascular • Hematological Disorders • Ischemic stroke
http://www.ncbi.nlm.nih.gov/pubmed/42798076
 
Dongxu Li; Shaoyue Huang; Xiaowei Qiu; Xiaoxuan Wang; Zhen Hong
 
Sep 27, 2026
 
Prev Next